CoChat

Randomized phase III trial evaluating the role of weight loss in adjuvant treatment of overweight and obese women with early breast cancer (Alliance A011401): study design

Open access
Ligibel, Jennifer A., Barry, William T., Alfano, Catherine, Hershman, Dawn L., Irwin, Melinda, Neuhouser, Marian, Thomson, Cynthia A., Delahanty, Linda, Frank, Elizabeth, Spears, Patty, Paskett, Electra D., Hopkins, Judith, Bernstein, Vanessa, Stearns, Vered, White, Julia, Hahn, Olwen, Hudis, Clifford, Winer, Eric P., Wadden, Thomas A., Goodwin, Pamela J. · 2017 · npj Breast Cancer
Cited by 102

The DOI matches its Crossref record; 7 of the 7 references it cites were found in a registry or an index.

Abstract

Excess body weight is a poor prognostic factor in women with early breast cancer, but the effect of weight loss on the risk of breast cancer recurrence and mortality in women who are overweight or obese at the time of breast cancer diagnosis has not been evaluated. The Alliance for Clinical Trials in Oncology Breast Cancer Weight Loss trial, also known as A011401, is testing the impact of a telephone-based weight loss program on invasive disease-free survival in 3136 women with a body mass index ≥27 kg/m 2 who have recently been diagnosed with stage II-III, HER-2 negative breast cancer. Secondary outcomes of the trial include the impact of the weight loss intervention on overall survival, body weight, physical activity, dietary intakes, incidence of comorbidities, serum biomarkers and patient reported outcomes. Participants are randomized 1:1 to a 2-year, telephone-based weight loss intervention or to an education control group. The intervention is delivered through 42 telephone calls, delivered by health coaches based at the Dana-Farber Cancer Institute. Calls are supplemented by an intervention workbook, as well as a number of tools to help facilitate weight loss. Intervention goals include loss of 10% of baseline body weight, achieved through caloric restriction and increased physical activity. This large-scale study testing the impact of purposeful weight loss after cancer diagnosis on the risk of breast cancer recurrence and mortality has the potential to make weight loss programs a standard part of breast cancer treatment.

Overview

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1038/s41523-017-0040-8

Cites

7 of 7 references verified0 citation errors · 0 not checkable

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Show all 7 references

Cited by

See all 102

Metadata

Authors
Ligibel, J. A., Barry, W. T., Alfano, C., Hershman, D. L., Irwin, M., Neuhouser, M., Thomson, C. A., Delahanty, L., Frank, E., Spears, P., Paskett, E. D., Hopkins, J., Bernstein, V., Stearns, V., White, J., Hahn, O., Hudis, C., Winer, E. P., Wadden, T. A., & Goodwin, P. J.
Venue
npj Breast Cancer
Published
2017-09-21
Volume
3
Issue
1
Pages
37-37
ISSN
2374-4677 (ISSN-L)
OpenAlex
W2753529942
Cited by
102
References
7
FWCI
4.42
Type
journal article
Language
en
Open access
gold

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: Randomized phase III trial evaluating the role of weight loss in adjuvant treatment of overweight and obese women with early breast cancer (Alliance A011401): study design. https://app.cochat.ai/papers/10.1038/s41523-017-0040-8
The paper
Ligibel, J. A., Barry, W. T., Alfano, C., Hershman, D. L., Irwin, M., Neuhouser, M., Thomson, C. A., Delahanty, L., Frank, E., Spears, P., Paskett, E. D., Hopkins, J., Bernstein, V., Stearns, V., White, J., Hahn, O., Hudis, C., Winer, E. P., Wadden, T. A., & Goodwin, P. J. (2017). Randomized phase III trial evaluating the role of weight loss in adjuvant treatment of overweight and obese women with early breast cancer (Alliance A011401): study design. npj Breast Cancer. https://doi.org/10.1038/s41523-017-0040-8

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.